CORRESP Filing
Humacyte, Inc.
Date: Sept. 18, 2025 · CIK: 0001818382 · Accession: 0001104659-25-091324
AI Filing Summary & Sentiment
File numbers found in text: 333-290231
Show Raw Text
CORRESP 1 filename1.htm September 18, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Alan Campbell Re: Humacyte, Inc. Registration Statement Filed on Form S-3 (the "Registration Statement") File No. 333-290231 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humacyte, Inc. (the "Company") hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on September 22, 2025, or as soon as practicable thereafter. Please contact Kerry S. Burke of Covington & Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Burke by telephone when this request for acceleration has been granted. Respectfully, Humacyte, Inc. By: /s/ Dale A. Sander Name: Dale A. Sander Title: Chief Financial Officer cc: Kerry S. Burke, Covington & Burling LLP